Company page
Aptabio Therapeutics, Inc.
Aptabio Therapeutics, Inc. is a public company listed under the ticker 293780, operating in the South Korean market. The company has a market capitalization of approximately 85.39 million USD. Aptabio focuses on developing innovative therapeutic solutions, contributing to advancements in healthcare.
- Ticker
- 293780:KRX
- Asset type
- Stock
- Market cap
- $85.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW